Professional Documents
Culture Documents
Covid 19 Sitrep 198 PDF
Covid 19 Sitrep 198 PDF
(COVID-19)
Situation Report – 198
Data as received by WHO from national authorities by 10:00 CEST, 5 August 2020
Highlights
WHO Regional Director for the Americas, Dr Carissa Etienne, has warned of disruptions to
regular health services due to COVID-19. Health workers have been redirected to care for
COVID-19 patients, people are hesitating to seek routine care due to fears of infection, and
global supply chains of medicines and equipment are strained.
This week, the world celebrates Breastfeeding Awareness Week to highlight the importance of
breastfeeding. WHO recommendations on the initiation and continued breastfeeding of
infants and young children also apply to mothers with suspected or confirmed COVID-19. As
WHO Director-General Dr Tedros mentioned in yesterday’s press briefing, ‘the many, many
benefits of breastfeeding for newborn babies and children substantially outweigh the potential
risks for COVID-19 infection.’ The WHO Regional Office for Europe has released an article on
Marko Obradovic, a paediatric nurse in Serbia, who describes the challenges and importance of
encouraging breastfeeding.
WHO has been supporting Suriname to address the COVID-19 pandemic and has assisted in
strengthening Suriname’s health system and through the Universal Health Coverage
Partnership, with the goal of helping the country achieve universal health coverage.
Today we include two reports in the ‘Subject in Focus’ below. The first discusses a recently
released WHO brief on estimating mortality from COVID-19, an extremely useful indicator of
the burden of disease that helps guide policy decisions. The second provides a summary of the
age and sex distribution of confirmed COVID-19 cases from the WHO COVID-19 global
surveillance database from January to July 2020.
Globally 18 354 342 cases (206 709) 696 147 deaths (5 116)
Africa 834 147 cases (8 875) 14 750 deaths (611)
Americas 9 841 842 cases (100 115) 367 934 deaths (2 600)
Eastern Mediterranean 1 585 458 cases (10 907) 41 601 deaths (399)
Europe 3 451 556 cases (21 623) 214 731 deaths (476)
South-East Asia 2 299 433 cases (56 777) 48 569 deaths (995)
Western Pacific 341 165 cases (8 412) 8 549 deaths (35)
Subject in Focus: Estimating COVID-19 mortality rates
An important characteristic of an infectious disease, particularly one caused by a novel
pathogen like SARS-CoV-2, the virus that causes COVID-19, is its severity, including its
ability to cause death.
Fatality rates help us understand the severity of a disease, identify at-risk populations, and
evaluate the quality of healthcare. Furthermore, differences in mortality between groups
of people and countries are important proxy indicators of relative risk of death that guide
policy decisions regarding scarce medical resource allocations.
However, this is no easy task. To better understand fatality rates, WHO has published a
scientific brief entitled ‘Estimating mortality from COVID-19’. This document is intended to
help countries estimate the proportion of deaths among identified confirmed cases (the
case fatality ratio, CFR) and, if possible, the proportion of deaths among all infected
individuals (the infection fatality ratio, IFR).
It looks in turn at how to calculate CFR and IFR, potential biases in the detection of cases
and deaths, approaches to minimizing these biases in estimating fatality rates during
ongoing epidemics, and how to take into account groups with different risk profiles, such
as older people and those with underlying illness.
During the COVID-19 pandemic, broad variations in CFR estimates have been published,
which may be misleading. This scientific brief concludes by providing some explanations
for these variations, and why making comparisons between countries can be problematic.
WHO will continue to support countries to improve their population data on COVID-19,
and improve their estimates of fatality rates, thereby maximizing the effectiveness of their
response by using such information to guide public health policy.
As of 30 July, 133 countries, territories and areas have reported CRF data and 54 countries,
territories and areas have reported weekly aggregate numbers.
A total of 16 298 556 confirmed cases had been reported globally. WHO received
information for 8 483 026 (52%) confirmed cases: 5 220 697 through CRF and 3 262 329
through weekly aggregate surveillance.
Of 8 483 026 confirmed cases received via CRF and weekly aggregate surveillance,
5 911 819 (70%) provided information on sex and 6 451 652 (76%) provided information on
age. Among the information received on sex, fifty-three percent (n=3 129 345) were male
and 47 per cent (n=2 782 474) were female.
The majority (64%) of cases were between the age of 25 to 64 years (Table 1).
From 24 February through 12 July 2020 (epidemiological weeks 9 to 28), the proportion of
cases aged 0-4 years, 5-24 years and 25-64 years have increased by seven-fold, six-fold and
three-fold, respectively (Figure 1). This trend may be explained by, but is not limited to, the
following factors:
• early detection and testing were initially focused on identifying cases with severe
symptoms, which are more frequently observed among older people;
• Changes to case definitions and general awareness are now leading to detection of
more mild cases, many of whom tend to be younger;
• expanded availability of testing with numerous drive-through testing, which likely
enables increased testing in communities;
• toutbreak hotspots shifting over time to countries with lower age profiles (e.g.
developing countries, or countries with substantial ex-patriate dormitory populations);
• risky behavior after easing of public health and social measures implemented to
reduce the spread of the virus, which may have increased transmission among
younger population.
0-4 1.2%
5-14 2.5%
15-24 9.6%
25-64 64%
65-84 19.4%
85+ 3.4%
Figure 1: Distribution by age of confirmed COVID-19 cases per week, COVID-19 WHO
surveillance, February to July 2020.
64 2 0 0 Sporadic cases 0
French Polynesia
Northern Mariana Islands 46 0 2 0 Pending 1
(Commonwealth of the)
New Caledonia 22 0 0 0 Sporadic cases 21
Subtotal for all regions 18 353 601 206 709 696 134 5 116
Other† 741 0 13 0 Not applicable -
Grand total 18 354 342 206 709 696 147 5 116
**See Annex 1 for data, table and figure notes.
Technical guidance and other resources
– To view all technical guidance documents regarding COVID-19, please go to this webpage.
– Updates from WHO regional offices
Case definitions
WHO periodically updates the Global Surveillance for human infection with coronavirus
disease (COVID-19) document which includes surveillance definitions.
A COVID-19 death is defined for surveillance purposes as a death resulting from a clinically
compatible illness in a probable or confirmed COVID-19 case, unless there is a clear
alternative cause of death that cannot be related to COVID-19 disease (e.g. trauma). There
should be no period of complete recovery between the illness and death.
Further guidance for certification and classification (coding) of COVID-19 as cause of death is
available here and here.
Annex 1: Data, table and figure notes
Caution must be taken when interpreting all data presented. Differences are to be expected
between information products published by WHO, national public health authorities, and
other sources using different inclusion criteria and different data cut-off times. While steps
are taken to ensure accuracy and reliability, all data are subject to continuous verification and
change. Case detection, definitions, testing strategies, reporting practice, and lag times differ
between countries/territories/areas. These factors, amongst others, influence the counts
presented, with variable underestimation of true case and death counts, and variable delays
to reflecting these data at global level.
The designations employed, and the presentation of these materials do not imply the
expression of any opinion whatsoever on the part of WHO concerning the legal status of
any country, territory or area or of its authorities, or concerning the delimitation of its
frontiers or boundaries. Dotted and dashed lines on maps represent approximate border
lines for which there may not yet be full agreement. Countries, territories and areas are
arranged under the administering WHO region.
The mention of specific companies or of certain manufacturers’ products does not imply
that they are endorsed or recommended by WHO in preference to others of a similar
nature that are not mentioned. Errors and omissions excepted, the names of proprietary
products are distinguished by initial capital letters.
[1]
All references to Kosovo should be understood to be in the context of the United Nations
Security Council resolution 1244 (1999). In the map, number of cases of Serbia and Kosovo
(UNSCR 1244, 1999) have been aggregated for visualization purposes.
*
A small number of countries/territories/areas report combined probable and laboratory-
confirmed cases; efforts are underway to identify these for notation in the data table.†Other:
includes cases reported from international conveyances.
Due to the recent trend of countries conducting data reconciliation exercises which remove
large numbers of cases or deaths from their total counts, WHO will now display such data as
negative numbers in the “new cases” / “new deaths” columns as appropriate. This will aid
readers in identifying when such adjustments occur. When additional details become
available that allow the subtractions to be suitably apportioned to previous days, graphics will
be updated accordingly. Prior situation reports will not be edited; see covid19.who.int for the
most up-to-date data.
i
Transmission classification is based on a process of country/territory/area self-reporting.
Classifications are reviewed on a weekly basis and may be revised as new information
becomes available. Differing degrees of transmission may be present within
countries/territories/areas; classification is based on the highest category reported within
a country/territory/area. Categories: